Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

remifentanil

remifentanil is a mu opioid receptor agonist.

NMPA: clinical trials
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — remifentanil
Class
—
Route
—
Patents
0
Programs
5
Data quality
0.70
← All drugs Search patents Pipeline programs Drug news hub Event calendar

Quick answer

remifentanil is a mu opioid receptor agonist.

Key facts

INN remifentanil
Mechanism Mu opioid receptor agonist

Mechanism of action

Mu opioid receptor agonist

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. Remifentanil Phase 3 · Chinese Academy of · Analgesia
  2. Remifentanil Approved · Hospital Authority · Labor Pain
  3. Esketamine, Sulfentanil or/and Remifentanil Unknown · Second Affiliated Hospital · Opioid Analgesic Adverse Reaction
  4. Remifentanil Unknown · Vera Therapeutics · Postoperative Pain
  5. remimazolam combined with remifentanil Unknown · First People's Hospital · Difficult or Failed Intubation

Frequently asked questions

What is remifentanil?

remifentanil is a mu opioid receptor agonist.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.